Clare S. Hardman

发表

Rorα is essential for nuocyte development

A. McKenzie, P. Fallon, F. Radtke, 2011, Nature immunology.

Role of NS1 antibodies in the pathogenesis of acute dengue infection

G. Ogg, G. Malavige, C. Jeewandara, 2018, bioRxiv.

IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent

G. Ogg, A. Simmons, A. McKenzie, 2021, Science Immunology.

Phospholipase activity of acyloxyacyl hydrolase induces IL‐22‐producing CD1a‐autoreactive T cells in individuals with psoriasis

G. Ogg, Randeep K. Singh, R. Etherington, 2021, European journal of immunology.

A stromal cell niche sustains ILC2-mediated type-2 conditioning in adipose tissue

J. Caamaño, A. Vidal-Puig, S. Carobbio, 2019, The Journal of experimental medicine.

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function.

I. Pavord, G. Ogg, Yi-Ling Chen, 2019, The Journal of allergy and clinical immunology.

Dengue virus co-opts innate type 2 pathways to escape early control of viral replication

G. Ogg, G. Malavige, Yi-Ling Chen, 2022, Communications Biology.

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells

I. Pavord, P. Klenerman, G. Ogg, 2019 .

Quantification of dengue virus specific T cell responses and correlation with viral load and clinical disease severity in acute dengue infection

G. Ogg, Dulharie T. Wijeratne, C. Jeewandara, 2018, bioRxiv.

Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a

G. Ogg, V. Cerundolo, Yi-Ling Chen, 2016, The Journal of experimental medicine.

Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production

G. Ogg, A. McKenzie, H. Jolin, 2016, The Journal of Immunology.

This information is current as Cytokine Production Functional NKp 30 Receptor Inducing Type 2 Group 2 Innate Lymphoid Cells Express

Ogg, A. McKenzie, H. Jolin, 2015 .

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Benjamin R. Szwejkowski, J. McMurray, I. Matthews, 2022, The Lancet.

CD1a promotes systemic manifestations of skin inflammation

G. Ogg, J. Rossjohn, Davinderpreet Mangat, 2022, Nature Communications.

Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite–derived phospholipase

Jorge Bernardino de la Serna, G. Ogg, V. Cerundolo, 2016, Science Translational Medicine.

Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation

S. Teichmann, M. Haniffa, G. Ogg, 2019, The Journal of experimental medicine.

Rorα is essential for nuocyte development

Freddy Radtke, Ute Koch, A. McKenzie, 2011, Nature Immunology.

Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis

G. Ogg, M. Londei, Yi-Ling Chen, 2019, Science Translational Medicine.

IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation

A. McKenzie, V. Panova, C. Hardman, 2012, European journal of immunology.

Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity.

A. McKenzie, James Cruickshank, Andrew N J McKenzie, 2012, The Journal of allergy and clinical immunology.

Multi-Modal Characterization of Monocytes in Idiopathic Pulmonary Fibrosis Reveals a Primed Type I Interferon Immune Phenotype

N. Ashley, C. Clelland, S. Taylor, 2021, Frontiers in Immunology.

Type-1 IFN primed monocytes in pathogenesis of idiopathic pulmonary fibrosis

N. Ashley, C. Clelland, S. Taylor, 2020, bioRxiv.

IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction.

I. Sayers, I. Hall, A. McKenzie, 2013, The Journal of allergy and clinical immunology.

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Benjamin R. Szwejkowski, J. McMurray, I. Matthews, 2022, The Lancet.

Interleukin-33, friend and foe in type-2 immune responses.

G. Ogg, Clare S. Hardman, 2016, Current opinion in immunology.

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells

R. Owens, G. Ogg, A. McKenzie, 2017, Science Immunology.

Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection

G. Ogg, G. Malavige, C. Jeewandara, 2018, Nature Communications.

Group A Streptococcus induces CD1a-autoreactive T cells and promotes psoriatic inflammation

G. Ogg, K. Ladell, H. Koohy, 2023, Science Immunology.

No Marked Manuscript has been provided as this manuscript has been reformatted from an Original Article to a Letter to the Editor.

I. Pavord, W. Liu, P. Klenerman, 2019, The Journal of allergy and clinical immunology.

IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction.

I. Sayers, I. Hall, A. McKenzie, 2013, The Journal of allergy and clinical immunology.

Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite–derived phospholipase

G. Ogg, V. Cerundolo, A. McKenzie, 2016, Science Translational Medicine.

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

G. Ogg, V. Erpenbeck, L. Xue, 2018, Airway pharmacology and treatment.

CD1 lipidomes reveal lipid-binding motifs and size-based antigen-display mechanisms

S. Gras, T. Cheng, D. Moody, 2023, Cell.